Clinical research consortia, multi-site pharmacovigilance networks, and cross-company data sharing arrangements all require the ability to query across multiple databases that cannot — for privacy, regulatory, or competitive reasons — be centralised. Federated search solves this by sending queries to each participating database and aggregating the results, rather than consolidating the data itself. When the federated query layer speaks in shared ontological terms, the results are semantically comparable even though the underlying data models differ.
The Shared Ontology as a Query Language
In a federated semantic search architecture, the shared ontology serves as a neutral query language that all participating sites understand. A query expressed as "find all patients who received a drug in class X and subsequently experienced an event of type Y within 30 days" is expressed in ontological terms — drug class X is an identifier in a shared pharmacological ontology; event type Y is an identifier in a shared adverse event ontology. Each site translates this query into its local representation, executes it against its local data, and returns a result count or a pseudonymised result set. The aggregation layer combines the results without having seen any raw patient data from any site.
Translation and Mapping Quality
The quality of federated search results depends directly on the quality of the ontology mappings at each site. If site A's local drug coding uses a different granularity than the shared pharmacological ontology — coding at the substance level where the ontology groups at the class level, or vice versa — the translation will either over-include or under-include. Regular mapping quality audits, based on test queries with known results at each site, are essential for maintaining result comparability across the federation over time.
Governance and Trust
Federated search requires governance structures that go beyond technical design. Participating sites must agree on the shared ontologies and their versions, on the query types that are permitted, on the minimum data set returned per query, and on the process for investigating anomalous results. A federated search result that suggests dramatically different incidence rates for a known adverse event at different sites is either clinically important or reflects a mapping error — and the governance process must be capable of distinguishing between the two quickly and reliably.
